Pecoits-Filho Roberto, Abensur Hugo, Cueto-Manzano Alfonso M, Dominguez Jorge, Divino Filho José Carolino, Fernandez-Cean Juan, Ortiz Ana Mireya, Moretta Gustavo, Ramos Alfonso, Sanabria Mauricio, Sesso Ricardo, Paniágua Ramon
Center for Health and Biological Sciences, Pontifícia Universidade Católica do Paraná, Imaculada Conceicão 1155, Curitiba, PR 80215-901, Brazil.
Perit Dial Int. 2007 May-Jun;27(3):316-21.
Latin America is a heterogeneous region comprised of 20 countries, former colonies of European countries, in which Latin-derived languages are spoken. According to the Latin American Society of Nephrology and Hypertension/Sociedad Latino Americana de Nefrologia e Hipertensión (SLANH), the acceptance rate for renal replacement therapy is 103 new patients per million population. In Latin America, hemodialysis is the predominant form of replacement therapy for end-stage renal disease; however, some countries employ peritoneal dialysis (PD) in 30% or more patients. In particular, Mexico is the country with the largest PD utilization in the world, and furthermore, it is estimated that approximately 25% of the world's PD population may be found Latin America. Data concerning clinical practice and long-term outcome of PD in Latin America are scarce, although regional registries are increasing in number and quality. In this review article, we present an overview of the situation of PD in several countries of Latin America, based on the registry of the SLANH, national registries, and personal communication with PD experts from different countries.
拉丁美洲是一个由20个国家组成的多样化地区，这些国家曾是欧洲国家的殖民地，人们使用源自拉丁语的语言。根据拉丁美洲肾脏病与高血压学会（SLANH）的数据，肾脏替代疗法的接受率为每百万人口中有103名新患者。在拉丁美洲，血液透析是终末期肾病替代疗法的主要形式；然而，一些国家有30%或更多的患者采用腹膜透析（PD）。特别是，墨西哥是世界上腹膜透析使用率最高的国家，此外，据估计，全球约25%的腹膜透析患者可能在拉丁美洲。尽管区域登记处的数量和质量都在增加，但关于拉丁美洲腹膜透析临床实践和长期结果的数据仍然很少。在这篇综述文章中，我们基于拉丁美洲肾脏病与高血压学会登记处、国家登记处以及与不同国家腹膜透析专家的个人交流，概述了拉丁美洲几个国家的腹膜透析情况。
